19 June 2019 in Journal of Biomaterials Science, Polymer Edition
Bacterial infection has become a serious clinical concern due to the emergence of drug-resistance and biofilm formation. Therefore, it is in great demand to develop efficient antimicrobial agents to treat bacterial infection without using antibiotics. Herein, we successfully prepared four quaternized ammonium PEI (QPEI: PEI1200-C2, PEI1200-C4, PEI1200-C6 and PEI1200-C8) using the commercial available PEI1200. Both PEI and four QPEI presented broad-spectrum antimicrobial activity against Gram-negative bacteria (E. coli, and P. aeruginosa) and Gram-positive bacteria (B. amyloliquefaciens and S. aureus), especially PEI1200-C6 showed the strongest antimicrobial activity with good biocompatibility at the MIC concentrations. Besides, PEI1200-C6 showed 4-16-fold better antibacterial effect than PEI1200, and fluorescent microscope imaging demonstrated that both of them could efficiently eradicate biofilms formed by four bacterial strains in vitro. As the accessible broad-spectrum antibacterial agents, PEI1200 and PEI1200-C6 are significant candidates to treat bacterial infections or eradicate biofilms on indwelling medical devices.
20 February 2024 in Journal of Materials Chemistry B
A drug delivery system (NPSBG@Cur) has been developed to respond to ROS and deliver the autophagy activator curcumin (Cur) to reduce the severity of AKI. This system works by activating autophagy and promoting the degradation of lipid droplets.
6 March 2019 in Journal of Materials Science: Materials in Medicine
21 April 2025 in ACS Biomaterials Science & Engineering
18 January 2019 in Chemical Papers
15 April 2026 in Chemical Engineering Journal